Jane Street Group, LLC Esperion Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	BUY	$4.81 - $11.92 $36,556 - $90,592	7,600 Added 10.3%	81,400 $407,000
Q3 2021 Nov 16, 2021	BUY	$11.34 - $21.37 $703,080 - $1.32 Million	62,000 Added 525.42%	73,800 $889,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $133,860 - $198,099	-6,900 Reduced 36.9%	11,800 $250,000
Q1 2021 May 18, 2021	BUY	$25.12 - $36.89 $90,432 - $132,804	3,600 Added 23.84%	18,700 $525,000
Q4 2020 Feb 17, 2021	SELL	$24.2 - $35.76 $108,900 - $160,920	-4,500 Reduced 22.96%	15,100 $393,000
Q3 2020 Nov 17, 2020	SELL	$31.18 - $52.71 $1.14 Million - $1.92 Million	-36,500 Reduced 65.06%	19,600 $729,000
Q2 2020 Aug 17, 2020	BUY	$30.04 - $51.31 $1.43 Million - $2.44 Million	47,500 Added 552.33%	56,100 $2.88 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $304,440 - $514,452	8,600 New	8,600 $513,000
Q1 2019 May 16, 2019	SELL	$40.11 - $53.57 $360,990 - $482,130	-9,000 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$36.99 - $59.11 $321,813 - $514,257	-8,700 Reduced 49.15%	9,000 $414,000
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $497,028 - $627,202	12,200 Added 221.82%	17,700 $785,000
Q2 2018 Aug 15, 2018	BUY	$36.2 - $76.4 $36,200 - $76,400	1,000 Added 22.22%	5,500 $216,000
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $408,828 - $500,712	-6,200 Reduced 57.94%	4,500 $325,000
Q4 2017 Feb 15, 2018	SELL	$43.47 - $67.43 $612,927 - $950,763	-14,100 Reduced 56.85%	10,700 $704,000
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $1.09 Million - $1.31 Million	24,800	24,800 $1.24 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.